BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23398365)

  • 1. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
    Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
    J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
    Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
    Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients.
    Tahani S; Dehghani L; Jahanbani-Ardakani H; Shaygannejad V; Fazli A; Hamidavi A; Eskandari N
    J Immunoassay Immunochem; 2019; 40(5):555-563. PubMed ID: 31422745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
    Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
    BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
    Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
    Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
    Wang KC; Tsai CP; Lee CL; Chen SY; Chin LT; Chen SJ
    Neuroscience; 2012 Dec; 226():510-6. PubMed ID: 23122444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
    Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
    J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
    Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
    Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls.
    Park KA; Kim J; Oh SY
    Acta Ophthalmol; 2014 Feb; 92(1):e57-65. PubMed ID: 23889747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
    Moussallieh FM; Elbayed K; Chanson JB; Rudolf G; Piotto M; De Seze J; Namer IJ
    Mult Scler; 2014 Apr; 20(5):558-65. PubMed ID: 24080986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
    Xu W; Li R; Dai Y; Wu A; Wang H; Cheng C; Qiu W; Lu Z; Zhong X; Shu Y; Kermode AG; Hu X
    J Neuroimmunol; 2013 Aug; 261(1-2):87-91. PubMed ID: 23726764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
    Harirchian MH; Tafakhori A; Taslimi S; Aghamollaii V; Shahsiah R; Gholipour T; Mohammadi F; Zare-Shahabadi A
    Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):98-104. PubMed ID: 25530145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
    Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
    Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.
    Bennett JL; de Seze J; Lana-Peixoto M; Palace J; Waldman A; Schippling S; Tenembaum S; Banwell B; Greenberg B; Levy M; Fujihara K; Chan KH; Kim HJ; Asgari N; Sato DK; Saiz A; Wuerfel J; Zimmermann H; Green A; Villoslada P; Paul F;
    Mult Scler; 2015 May; 21(6):678-88. PubMed ID: 25662342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica].
    You XF; Ye J; Li CJ; Liao ZY; Sun H
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2477-80. PubMed ID: 21092475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
    Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
    Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.